Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC)
Rhea-AI Filing Summary
Anquillare Mark V reported acquisition or exercise transactions in this Form 4 filing.
Teladoc Health, Inc. reported that director Mark V. Anquillare received a grant of 37,425 Restricted Stock Units on 2026-08-03, each representing a contingent right to one share of common stock. One-third of the units vest on the first anniversary of the grant, with the remainder vesting in eight substantially equal quarterly installments, leaving him with 37,425 RSUs directly held after the award.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Anquillare Mark V
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F2 | 37,425 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 37,425 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- F2. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Key Figures
RSUs granted: 37425.0000 RSUs
Grant price per unit: 0.0000 per RSU
RSUs following transaction: 37425.0000 RSUs
+1 more
4 metrics
RSUs granted
37425.0000 RSUs
Restricted Stock Units granted to director on 2026-08-03
Grant price per unit
0.0000 per RSU
Reported transaction price for the RSU award
RSUs following transaction
37425.0000 RSUs
Total Restricted Stock Units directly held after the grant
Transaction date
2026-08-03
Date of the RSU grant to the director
Key Terms
Restricted Stock Units, contingent right, vest, underlying security
4 terms
Restricted Stock Units financial
"security_title: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
vest financial
"One-third of the restricted stock units vest on the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
underlying security financial
"underlying_security_title: Common Stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Teladoc Health (TDOC) grant to Mark V. Anquillare?
Teladoc Health granted director Mark V. Anquillare 37,425 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Teladoc Health common stock, providing him with equity-based compensation aligned with the company’s future share performance.
When was the new RSU grant to the Teladoc Health (TDOC) director made?
The RSU grant to Mark V. Anquillare was dated 2026-08-03. This date starts the vesting timeline for the award, which includes an initial one-year cliff vest followed by additional vesting in substantially equal quarterly installments.
How do the 37,425 Teladoc Health (TDOC) RSUs vest for Mark V. Anquillare?
For this award, one-third of the 37,425 RSUs vest on the first anniversary of the grant. The remaining RSUs then vest in eight substantially equal quarterly installments, spreading vesting over an additional two years after the initial cliff period.
What is the price per unit for Mark V. Anquillare’s Teladoc Health (TDOC) RSU grant?
The reported transaction price per RSU is $0.0000 per unit. This reflects that the grant is a compensatory equity award, not a market purchase, and does not require the director to pay a cash exercise price for the underlying common shares.
How many Teladoc Health (TDOC) RSUs does Mark V. Anquillare hold after this grant?
Following this grant, Mark V. Anquillare is reported as directly holding 37,425 Restricted Stock Units. These RSUs, once vested and settled, would deliver an equivalent number of Teladoc Health common shares, subject to the award’s vesting schedule and other applicable terms.